Last reviewed · How we verify
NCT04917406
Effect of Iontophoresis vs. Ultrasound and Iontophoresis in Plantar Fasciitis". Plantar Fasciitis"
NA trial testing Application of lidocaine together with dexamethasone in Iontophoresis in 76 participants. Completed in 1 October 2021.
15 September 2021
Quick facts
| Lead sponsor | University of Seville |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 76 |
| Start date | 20 May 2021 |
| Primary completion | 15 September 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Application of lidocaine together with dexamethasone — full drug profile →
- Application of ultrasound as physical therapy
Conditions studied
- Iontophoresis — all drugs for Iontophoresis →
- Ultrasound Therapy; Complications — all drugs for Ultrasound Therapy; Complications →
- Fasciitis, Plantar — all drugs for Fasciitis, Plantar →
- Pain, Acute — all drugs for Pain, Acute →
Sponsor
University of Seville
Who can join
Adults 18 to 65, any sex, with Iontophoresis or Ultrasound Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Plantar fasciitis is inflammation of plantar fascia.The main symptom of plantar fasciitis manifests itself as localized pain in the inner area of the foot and increases in intensity after long periods of standing or resting. Its etiology is multifactorial and risk factors include overweight, female gender, physical exercise (impact sports), biomechanical imbalances of the foot and possible dysfunction of the functional twin-ankle-plantar system.Generally speaking, conservative measures are recommended as initial treatment for plantar fasciitis, and in situations where these are ineffective, corticosteroids are sometimes administered. At the local level, the route of administration can be by infiltration or iontophoresis.Iontophoresis consists of administering a drug through the skin by applying an electric current locally. This technique can be considered as a safe and effective method within the SLTF (Transcutaneous Drug Delivery Systems). It consists of introducing ions through the skin by means of electricity using a direct current, with an electrode carrying a positive charge (anode) and a negative charge (cathode). Its administration is produced thanks to the repulsive force to carry the compound through the skin by means of galvanic current. This study aims to assess whether treatment with iontophoresis in subjects with plantar fasciitis can show a more positive evolution in pain after a 6-week treatment period (treatment frequency: 1 time per week) versus ultrasound (3 times per week) for 6 weeks.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of the Short-Term Effect between Iontophoresis and Radial Extracorporeal Shockwave Therapy in the Treatment of Plantar Fasciitis: A Randomized Controlled Trial.
Pabón-Carrasco M, Coheña-Jiménez M, Pérez-Belloso AJ, Algaba-Del-Castillo J, et al · · 2024 · cited 2× · PMID 38921337 · DOI 10.3390/healthcare12121223
Verify or expand the search:
- PubMed search for NCT04917406
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Seville trials
Trials by the same sponsor.
- NCT07501273 — Analgesic Effect of a Biophotonic Foot Massage Cream · NA · not yet recruiting
- NCT07387627 — Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders · NA · not yet recruiting
- NCT07361887 — Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. · NA · recruiting
- NCT06978582 — Effectiveness and Safety of a Tele-Rehabilitation Program on Fatigue and Related Variables in Chronic Fatigue Syndrome a · NA · active not recruiting
- NCT07208045 — Cultural Adaptation, Validation, and Evaluation of the Programme for Promotion of Healthy Affective-Sexual Behaviours in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04917406 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Seville
- Last refreshed: 3 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04917406.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing